Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ–mediated inflammatory death program
Science Signaling · 07.07.2026 · 19 (945)
DOI: 10.1126/scisignal.adz7366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, erschienen am 07.07.2026. Verfasst von Nicholas D Sun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: I-kappa B Kinase, Interferon-gamma, Protein Serine-Threonine Kinases, Apoptosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Cytotoxic T cells produce the cytokine interferon-γ (IFN-γ). We sought to determine whether IFN-γ directly kills target cells and found that T cells used IFN-γ to kill murine melanoma cells lacking the kinases TBK1 and IKKε. In the absence of both kinases, IFN-γ induced the production of TNF receptor 1 (TNFR1) and the sensor Z-DNA binding protein 1 (ZBP1) in the tumor cells to stimulate receptor-interacting protein kinase 1 (RIPK1)–dependent apoptosis in a cell-autonomous manner. IFN-γ also enhanced the activation of nuclear factor κB (NF-κB) signaling in a TNFR1-dependent manner in cells deficient in both TBK1 and IKKε. Because IFN-γ–induced apoptosis occurred in a transcription-dependent manner with slow kinetics, STAT1 and NF-κB cooperated to activate the expression of inflammatory genes in the dying cells. Thus, IFN-γ–induced cell death was accompanied by an inflammatory signature in the absence of TBK1 and IKKε. TBK1 and IKKε not only mediated the induction of type I IFN but also inhibited RIPK1-dependent death and NF-κB–dependent inflammation. Therefore, we propose that these kinases may have gained these intertwined functions so that cells infected by pathogens that produce antagonists of TBK1 and IKKε are eliminated by IFN-γ–secreting T cells in an inflammatory manner to compensate for the inhibition of type I IFN production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.
- Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
- Columbia Center for Genetic Errors of Immunity, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Center for Individualized Medicine, Mayo Clinic, Rochester, MN 55905, USA.
ORCID-Profile: Nicholas D Sun, Allison R Carr, Yogesh Chawla, Jun Zhong, Matthew C Guttormson, Mark Chan, Michelle A Hsu, Haidong Dong, Dusan Bogunovic, Akhilesh Pandey, Laura M Rogers, Adrian T Ting
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- National Institutes of Health
- Mayo Clinic
Zitieren
APA
Sun, N. D., Carr, A. R., Krogman, E. N., Chawla, Y., Zhong, J., Guttormson, M. C., Chan, M., Hsu, M. A., Dong, H., Bogunovic, D., Pandey, A., Rogers, L. M., & Ting, A. T. (2026). Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ–mediated inflammatory death program. Science Signaling, 19(945). https://doi.org/10.1126/scisignal.adz7366
Vancouver
Sun ND, Carr AR, Krogman EN, Chawla Y, Zhong J, Guttormson MC, et al. Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ–mediated inflammatory death program. Science Signaling. 2026;19(945). doi:10.1126/scisignal.adz7366
BibTeX
@article{Sun2026,
author = {Sun, Nicholas D and Carr, Allison R and Krogman, Erica N and Chawla, Yogesh and Zhong, Jun and Guttormson, Matthew C and Chan, Mark and Hsu, Michelle A and Dong, Haidong and Bogunovic, Dusan and Pandey, Akhilesh and Rogers, Laura M and Ting, Adrian T},
title = {Loss of the kinases TBK1 and IKKε sensitizes target cancer cells to T cell killing through an IFN-γ–mediated inflammatory death program},
journal = {Science Signaling},
year = {2026},
volume = {19},
number = {945},
doi = {10.1126/scisignal.adz7366}
}
EUVIMED